LL&M Great Debates | Clinical Brief on Hematologic Malignancies

A Clinical Brief on Current Controversies in Hematologic Malignancies

Download a clinical brief outlining real controversies in lymphoma, leukemia, myeloma, and CLL that will be debated at LL&M Great Debates.

June 27–28, 2026 | New York, NY July 25–26, 2026 | Dallas, TX
Download the Clinical Brief

Where Clinical Decisions Get Complicated

In hematologic malignancies, the challenge is often not a lack of data, but how to apply it.

Different approaches are supported by evidence, yet lead to different treatment decisions in practice.

This brief gives you a clear view of where those decisions diverge, how experienced clinicians approach them, and what to consider when applying them in your own patients.

Use this as a reference point to evaluate how you’re approaching these decisions today and where alternative strategies may warrant consideration.

Get the Clinical Brief

Fill out the form below and we'll send your Clinical Brief immediately.

Inside the Clinical Brief

A preview of the clinical questions explored:

Relapsed Hodgkin Lymphoma
Is transplant still necessary, or can novel agents replace it?
Frontline CLL
Should time-limited therapy be preferred across risk groups?
AML
When should targeted therapy enter the treatment pathway?
Myeloma
Is transplant still central, or does CAR T/bispecifics change the equation?

What You’ll Get

  • The core clinical question in each debate, stated plainly
  • Both sides of the argument and the evidence behind each
  • Where expert opinion and guideline consensus diverge
  • Practical framing you can apply to your own patients

This Is Only Part of the Discussion

The Clinical Brief shows the questions. The live meeting shows how clinicians work through them—expert to expert, evidence to practice.

Explore the Debates